Caris Life Sciences Launches Multi Cancer Detection Blood Test Caris Detect

July 01, 2026
Caris Life Sciences has launched Caris Detect, a blood test that uses whole genome and transcriptome sequencing with artificial intelligence to identify early cancer signals across multiple cancer types.

Caris Life Sciences announced in a press release the launch of Caris Detect, a blood test designed for early detection of multiple cancer types. The test uses whole genome sequencing, whole transcriptome sequencing, and artificial intelligence to analyze molecular and biological signals linked to cancer.

Caris Detect examines DNA, RNA, and other biological patterns to identify cancer signals at early stages. The system is supported by Caris' molecular profiling database, which includes over one million cases and more than 50 billion molecular markers. This dataset enables AI models to detect subtle disease indicators across various cancer types.

The product launch follows data from the Caris Detect ACHIEVE 1 study, which showed strong performance in detecting cancer signals across multiple types. Caris stated it will continue research to expand the test's clinical evidence and capabilities through future studies.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

07/01
ALR Technologies to Acquire CGM Medical Technology for $45 Million and 200 Million Shares
07/01
Inductive Bio Connects ADMET Prediction Models to Claude for Drug Discovery
07/01
Basecamp Research Integrates EDEN Models into Claude Science for Antibiotic and Vaccine Design
07/01
SciBase Files FDA 510(k) to Expand Nevisense Use for Non-Melanoma Skin Cancer
07/01
PreOncology Launches AI-Based Early Cancer Detection Program

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like